Abbott Laboratories

Merck & Co., Inc.

National Headache Foundation


CME Monograph

National Headache Foundation.

"Advances in Migraine Prophylaxis: Current state of the art and future prospects" is a continuing medical education program featuring advances in migraine prophylaxis, including botulinum toxin type A, a promising new therapeutic modality.


© KAPLAN Communications
Not to be reproduced in any way without the expressed permission of KAPLAN Communications

Legal